Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

Clinical trial NCT04724837 · COMPLETED

Trial details

NCT number: NCT04724837
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2021-04-28
Primary completion: 2023-06-01
Enrollment: 542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.